New Agents for Heart Failure: Sacubitril/Valsartan

Похожие видео

New Agents for Heart Failure: Ivabradine

Entresto

Профессор Милтон Пакер: «Сердечная недостаточность: существуют ли ограничения для антидиабетическ...

PARADIGM-HF — The Experts’ Discussion

Sacubitril/Valsartan : Should We Reshuffle the Deck in the Treatment of HF?

Pearls and Pitfalls in the Management of CHF

Heart Failure Case Studies

PARADIGM HF/ Entresto | the real Evidence Based Medicine perspective

Optimizing Severe Asthma Care: Part 1 Phenotypes and Biomarkers

Сердечная недостаточность: BNP

Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'

Managing Heart Failure – Michelle M. Kittleson, MD, PhD - 2020 Healing the Heart

Неотложная помощь при аритмиях 101 с доктором Брауном

Update on Novel Therapies for Heart Failure (Milton Packer, MD) February, 10, 2017

Evolving Pathophysiology of Heart Failure

Legacy Health Use of ARNI and SGLT 2 Inhibitors in Systolic CHF

Entresto - Is It Really A Miracle Drug?

HFSA 2022: PROVE-HF: Effect of Sacubitril/Valsartan in HFrEF Pts With MR | Dr James L Januzzi

New Hope for Heart Failure patients- A gamechanger arrives

Using SGLT2-inhibitors to treat cardiac patients with diabetes